SKIP TO CONTENT
A claim drafting strategy assuring the patent subject matter eligibility of diagnostic gene signature method claims is discussed in light...
Sep
24
2024
Posts by: Christopher D. Southgate, J.D., Ph.D.
Share
Categories
Articles by Attorneys
Articles by Practices
Archives
Related Posts
- Branching Misunderstandings: When Chemistry Meets Legalese in Alnylam v. Moderna
- Patent Eligibility of Diagnostic Gene Signature Method Claims
- Leveraging Patent Term Adjustment Strategies to Add Value to Your Company’s Patent Portfolio
- Protecting Your innovation When the Lights Go Out on Noncompetes